Ani pharmaceuticals launches promethazine hydrochloride and dextromethorphan hydrobromide oral solution

Princeton, n.j., sept. 13, 2024 (globe newswire) --  ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the launch of promethazine hydrochloride and dextromethorphan hydrobromide oral solution, 6.25 mg/15 mg per 5 ml.
ANIP Ratings Summary
ANIP Quant Ranking